-Daniel R Weinberger Researcher Activity Profile

Research Author Detailed Information 

Daniel R Weinberger Publication Rate By Year

Daniel R Weinberger has published 1 paper(s) in 1994, 1 paper(s) in 2006, 42 paper(s) in 2007, 7 paper(s) in 2008, for a total of 51 research publications in total.

Daniel R Dr Weinberger Author Information

LAST NAME: weinberger

FIRST NAME: Daniel R

INITIALS: dr

AFFILIATION:

Papers

Daniel R Weinberger's Publication Record

1. Biological phenotypes and genetic research on schizophrenia. Year Published: 2006
Clinical Brain Disorders Branch, Intramural Research Program, National Institute of Mental Health, 10 Center Drive, Bethesda, MD 20892, USA.
2. Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls. Year Published: 2007
Clinical Brain Disorders Branch, Intramural Research Program, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, USA. HydeT@mail.nih.gov
3. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. Year Published: 2007
SAIC-Frederick, NCI, National Institutes of Health, Frederick, Maryland 21702, USA.
4. Amygdala activation in affective priming: a magnetoencephalogram study. Year Published: 2007
Clinical Brain Disorders Branch, IRPP/NIMH/NIH/DHHS, Bethesda, Maryland, USA.
5. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Year Published: 2007
Genes, Cognition and Psychosis Program, Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA.
6. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Year Published: 2007
Clinical Brain Disorders Branch, Genes, Cognition, and Psychosis Program, Intramural Research Program, National Institute of Mental Health, NIH, US Department of Health and Human Services, Bethesda, MD 20892-1379, USA. straubr@intra.nimh.nih.gov
7. Asymmetrical ventricular enlargement in Parkinson's disease. Year Published: 2007
Department of Neurology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina 27599-7025, USA, and University Hospital, Vancouver, British Columbia, Canada. xuemei@med.unc.edu
8. Schizophrenia drug says goodbye to dopamine. Year Published: 2007
9. Genetic contributions to white matter architecture revealed by diffusion tensor imaging in Williams syndrome. Year Published: 2007
Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892, USA. marencos@mail.nih.gov
10. Perfusion imaging: Quantitative cerebral blood flow mapping in humans using magnetic resonance imaging. Year Published: 2007
Clinical Brain Disorders Branch, National Institute of Mental Health National Institutes of Health, Bethesda, MD, USA.
11. Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms. Year Published: 2007
Clinical Brain Disorder Branch, Genes, Cognition, and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1385, USA. seiy@mail.nih.gov
12. fMRI evidence for functional epistasis between COMT and RGS4. Year Published: 2007
13. Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Year Published: 2007
14. Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene. Year Published: 2007
Behavioral Endocrinology Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
15. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Year Published: 2007
The Osaka-Hamamatsu Joint Research Center for Child Mental Development, Osaka University Graduate School of Medicine, Yamadaoka, Suita, Osaka, Japan. hashimor@psy.med.osaka-u.ac.jp
16. {alpha}7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. Year Published: 2007
17. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. Year Published: 2007
Genes, Cognition, and Psychosis Program, Clinical Brain Disorders Branch, National Institutes of Health, United States Department of Health and Human Services, Bethesda, Maryland 20892-1385, USA.
18. Amygdala activation in affective priming: a magnetoencephalogram study. Year Published: 2007
Clinical Brain Disorders Branch, IRPP/NIMH/NIH/DHHS, Bethesda, Maryland, USA.
19. Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression. Year Published: 2007
Clinical Brain Disorders Branch, Genes, Cognition, and Psychosis Program, Intramural Research Program, National Institute of Mental Health, NIH, US Department of Health and Human Services, Bethesda, MD 20892-1379, USA. straubr@intra.nimh.nih.gov
20. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization. Year Published: 2007
Genes, Cognition, and Psychosis Program, Clinical Brain Disorders Branch, National Institutes of Health, United States Department of Health and Human Services, Bethesda, Maryland 20892-1385, USA.
21. Catechol-O-Methyltransferase Val158Met Modulation of Prefrontal Parietal Striatal Brain Systems during Arithmetic and Temporal Transformations in Working Memory. Year Published: 2007
Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, and Psychiatry Research Division, The Zucker Hillside Hospital, Glen Oaks, New York 11004
22. Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory. Year Published: 2007
Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA. tanh@mail.nih.gov
23. Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. Year Published: 2007
Intramural Research Program, National Institute of Mental Health, NIH, Bethesda, MD 20892-1385, USA.
24. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Year Published: 2007
Clinical Brain Disorders Branch, Section on Neuropathology, DIRP/NIMH/NIH, Bethesda, MD, 20892-1385, USA.
25. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment. Year Published: 2007
University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina, United States.
26. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Year Published: 2007
Genes, Cognition and Psychosis Program, Clinical Brain Disorders Branch, National Institute of Mental Health, NIH, Bethesda, MD 20892, USA.
27. Catechol-O-methyltransferase Val158Met modulation of prefrontal-parietal-striatal brain systems during arithmetic and temporal transformations in working memory. Year Published: 2007
Clinical Brain Disorders Branch, Genes Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA. tanh@mail.nih.gov
28. Neuregulin-1 Regulates Cell Adhesion via an ErbB2/Phosphoinositide-3 Kinase/Akt-Dependent Pathway: Potential Implications for Schizophrenia and Cancer. Year Published: 2007
Genes, Cognition and Psychosis Program, Intramural Research Program, National Institute of Mental Health, National Institutes of Health (NIH), Bethesda, Maryland, United States of America.
29. BDNF Val(66)Met polymorphism significantly affects d' in verbal recognition memory at short and long delays. Year Published: 2008
Clinical Brain Disorders Branch, NIMH, Bethesda, MD 20892, USA; Department of Psychiatry Research, The Zucker Hillside Hospital, North Shore-Long Island Jewish Health System, Glen Oaks, NY 11004, USA.
30. Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms. Year Published: 2007
Clinical Brain Disorder Branch, Genes, Cognition, and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD 20892-1385, USA. seiy@mail.nih.gov
31. fMRI evidence for functional epistasis between COMT and RGS4. Year Published: 2007
32. Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Year Published: 2007
33. Frontal release signs and cognition in people with schizophrenia, their siblings and healthy controls. Year Published: 2007
Clinical Brain Disorders Branch, Intramural Research Program, National Institutes of Health, 10 Center Drive, Bethesda, Maryland 20892, USA. HydeT@mail.nih.gov
34. Pituitary adenylate cyclase-activating polypeptide is associated with schizophrenia. Year Published: 2007
The Osaka-Hamamatsu Joint Research Center for Child Mental Development, Osaka University Graduate School of Medicine, Yamadaoka, Suita, Osaka, Japan. hashimor@psy.med.osaka-u.ac.jp
35. Genetic variation in catechol-o-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Year Published: 2007
Clinical Brain Disorders Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland.
36. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Year Published: 2007
Clinical Brain Disorders Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
37. A validated network of effective amygdala connectivity. Year Published: 2007
Unit for Systems Neuroscience in Psychiatry, Bethesda, MD 20892-1257, USA.
38. Alpha7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1. Year Published: 2007
Intramural Research Program, National Institute of Mental Health, NIH, Bethesda, MD 20892-1385, USA.
39. The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity. Year Published: 2008
UCLA Semel Institute for Neuroscience and Human Behavior, 300 Medical Plaza, Rm. 2251, Los Angeles, CA 90095-6968. keithn@ucla.edu.
40. Is gray matter volume an intermediate phenotype for schizophrenia? A voxel-based morphometry study of patients with schizophrenia and their healthy siblings. Year Published: 2008
Genes, Cognition and Psychosis Program, National Institute of Mental Health, Division of Intramural Research, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892-1364, USA.
41. Heritability of brain morphology related to schizophrenia: a large-scale automated magnetic resonance imaging segmentation study. Year Published: 2008
Neuroimaging Core Facility, Genes, Cognition and Psychosis Program, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland 20892, USA.
42. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Year Published: 2007
Clinical Brain Disorders Branch, Section on Neuropathology, DIRP/NIMH/NIH, Bethesda, MD, 20892-1385, USA.
43. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment. Year Published: 2007
University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina 27510-7160, United States. robert_mcclure@med.unc.edu
44. Local pharmacological manipulation of extracellular dopamine levels in the dorsolateral prefrontal cortex and caudate nucleus in the rhesus monkey: an in vivo microdialysis study. Year Published: 1994
Clinical Brain Disorders Branch, NIMH/NIH, NIMH Neurosciences Center at St. Elizabeths Hospital, Washington, DC 20032.
45. Genetic variation in MAOA modulates ventromedial prefrontal circuitry mediating individual differences in human personality. Year Published: 2008
[1] 1Neuroimaging Core Facility, National Institute for Mental Health, NIH, DHHS, Bethesda, MD, USA [2] 2Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute for Mental Health, NIH, DHHS, Bethesda, MD, USA.
46. Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? Year Published: 2008
1Clinical Brain Disorders Branch, Genes, Cognition and Psychosis Program, National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, MD, USA.
47. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Year Published: 2008
Department of Psychology, UCLA Semel Institute for Neuroscience and Human Behavior, 300 Medical Plaza, Rm. 2251, Los Angeles, CA 90095-6968, USA. keithn@ucla.edu
48. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Year Published: 2007
Clinical Brain Disorders Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.
49. Expression of oligodendrocyte-associated genes in dorsolateral prefrontal cortex of patients with schizophrenia. Year Published: 2007
Clinical Brain Disorders Branch, Section on Neuropathology, DIRP/NIMH/NIH, Bethesda, MD, 20892-1385, USA.
50. Absence of regional brain volume change in schizophrenia associated with short-term atypical antipsychotic treatment. Year Published: 2007
University of North Carolina at Chapel Hill, Department of Psychiatry, Chapel Hill, North Carolina 27510-7160, United States. robert_mcclure@med.unc.edu
51. Genetic variation in catechol-O-methyltransferase: effects on working memory in schizophrenic patients, their siblings, and healthy controls. Year Published: 2007
Clinical Brain Disorders Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland, USA.